
Centene (CNC) Stock Forecast & Price Target
Centene (CNC) Analyst Ratings
Bulls say
Centene's positive outlook is supported by a significant improvement in Medicaid Health Benefit Ratio (HBR), which increased to 93.4%, reflecting a year-over-year enhancement of approximately 150 basis points. The company's membership in 3.5+ Star plans also rose to 60%, indicating higher quality ratings and potential for increased revenue. Moreover, the anticipated composite rate improvement of approximately 5.5% for the upcoming periods, coupled with a strong performance in Medicare and PDP memberships, further underscores Centene's robust growth potential in the government-sponsored healthcare market.
Bears say
Centene faces significant challenges, including a projected decline in low-cost Silver positions within its portfolio, which is expected to drop from 55% in 2025 to 42% in 2026, indicative of potential revenue pressure in the coming years. The company's recent earnings report suggested that its commercial Health Benefits Ratio (HBR) decreased to 89.9%, falling short of guidance, which raises concerns about its profitability and cost management amid changing market dynamics. Furthermore, ongoing risks related to government pay exposure, regulatory changes, and utilization pressures may adversely impact Centene's financial stability and growth prospects, contributing to a negative outlook for its stock.
This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.
Centene (CNC) Analyst Forecast & Price Prediction
Start investing in Centene (CNC)
Order type
Buy in
Order amount
Est. shares
0 shares